Healthcare Triangle shares surge 11.43% intraday after acquiring Teyame.AI and announcing $34M acquisition revenue.

Healthcare Triangle, Inc. (HCTI) surged 11.43% intraday following announcements of strategic growth initiatives. The stock’s rally coincided with the company signing a Letter of Intent (LOI) to acquire Teyame.AI, a $34 million FY2025 revenue target, and processing $20 million in revenue through its subsidiary QuantumNexis’ Ezovion platform. These developments underscored HCTI’s aggressive expansion strategy in AI-driven healthcare technology. Additionally, warrant inducement agreements raised approximately $1.63 million, bolstering liquidity. Recent regulatory compliance measures, including a reverse stock split, also positioned the company to maintain Nasdaq listing status. Collectively, the acquisition progress, revenue milestones, and capital-raising efforts reinforced investor confidence in HCTI’s turnaround and growth potential.